Concepedia
Statistics
Publications
21
Citations
2.1K
H-Index
16
Active since
1975
Affiliations
University of Utah(Current)
California Institute for Medical Research
Parkinson's Foundation
Johns Hopkins University
Johns Hopkins Medicine
Kevin T. Finnegan is an author at University of Utah specializing in neuropharmacology, pharmacology, and neuroscience.
Publications per year
1975–2019
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
Zobair M. Younossi, Vlad Ratziu, Rohit Loomba et al. · The Lancet · 2019 · 1.2K citations · Full text
Medicine, Internal Medicine, Pharmacology +8
Protection against DSP-4-induced neurotoxicity by deprenyl is not related to its inhibition of MAO B
Kevin T. Finnegan, John J. Skratt, Ian Irwin et al. · European Journal of Pharmacology · 1990 · 124 citations
Life Sciences, Neuroscience, Pharmacology +10
Aminergic Metabolites in Cerebrospinal Fluid of Humans Previously Exposed to MDMA: Preliminary Observations<sup>a</sup>
G.A. Ricaurte, Kevin T. Finnegan, Ian Irwin et al. · Annals of the New York Academy of Sciences · 1990 · 101 citations
Life Sciences, Pharmacology, Toxicology +11
The relationships between aging, monoamine oxidase, striatal dopamine and the effects of MPTP in C57BL/6 mice: a critical reassessment
Ian Irwin, Kevin T. Finnegan, Louis E. DeLanney et al. · Brain Research · 1992 · 96 citations
Life Sciences, Neuroscience, Pharmacology +17
Phencyclidine-induced rotational behavior in rats with nigrostriatal lesions and its modulation by dopaminergic and cholinergic agents
Kevin T. Finnegan, Marilyn Kanner, Herbert Y. Meltzer · Pharmacology Biochemistry and Behavior · 1976 · 88 citations
Medicine, Neuroscience, Pharmacology +16
1–5 of 21